REQUEST A DEMO
Total
USD $0.00
Search more companies

Bionutrec S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Bionutrec S.A.S. Profile Updated: September 06, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Bionutrec S.A.S. is a company in Colombia, with a head office in Yumbo. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on November 26, 2013. 34 (2023) employees currently work for Bionutrec S.A.S.. In 2022, the company reported a net sales revenue increase of 61.04%. During that time, Bionutrec S.A.S.’s total assets grew by 2.25%. The enterprise’s net profit margin increased by 8.88% in 2022.

Headquarters
Cl 15 # 32 - 450
Yumbo; Valle del Cauca;

Contact Details: Purchase the Bionutrec S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Bionutrec S.A.S. report to view the information.
Outstanding Shares:
Purchase the Bionutrec S.A.S. report to view the information.
Incorporation Date:
November 26, 2013
Key Executives
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Bionutrec S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
61.04%
Total operating revenue
65.53%
Operating profit (EBIT)
N/A
EBITDA
12470.14%
Net Profit (Loss) for the Period
532.32%
Total assets
2.25%
Total equity
39.85%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
8.88%
Return on Equity (ROE)
22.19%
Quick Ratio
1.16%
Cash Ratio
0.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?